|1||NCT01431326||Recruiting||Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care||
||Other / NIH / Industry||
||10000||All||up to 21 Years (Child, Adult)||NCT01431326||Pro00029638
|PTN_POPS||November 2011||February 2020||February 2020||September 9, 2011||April 4, 2019||
|A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure||
||5081||All||18 Years to 95 Years (Adult, Older Adult)||NCT01877915||CR101940
|COMMANDER HF||September 10, 2013||April 19, 2018||April 19, 2018||June 14, 2013||May 10, 2019||May 10, 2019||
† Study has passed its completion date and status has not been verified in more than two years.